Search

Your search keyword '"Ma, LuLin"' showing total 33 results

Search Constraints

Start Over You searched for: Author "Ma, LuLin" Remove constraint Author: "Ma, LuLin" Publisher elsevier bv Remove constraint Publisher: elsevier bv
33 results on '"Ma, LuLin"'

Search Results

4. Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial

5. Prognostic Value of Tumor Size in Patients with Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis

10. Dose escalation and expansion (phase Ia/Ib) study of GLS-010, a recombinant fully human antiprogrammed death-1 monoclonal antibody for advanced solid tumors or lymphoma

11. Completely laparoscopic versus open radical nephrectomy and infrahepatic tumor thrombectomy: Comparison of surgical complexity and prognosis

17. Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial

19. Application of fluorescence in situ hybridization in the detection of bladder transitional-cell carcinoma: A multi-center clinical study based on Chinese population

24. Current status of diagnosis and treatment of bladder cancer in China – Analyses of Chinese Bladder Cancer Consortium database

25. Percent free prostate-specific antigen for prostate cancer diagnosis in Chinese men with a PSA of 4.0–10.0 ng/mL: Results from the Chinese Prostate Cancer Consortium

26. WITHDRAWN: Percent free prostate-specific antigen for prostate cancer diagnosis in Chinese men with a PSA of 4.0–10.0 ng/mL: Results from the Chinese Prostate Cancer Consortium

27. WITHDRAWN: Current status of diagnosis and treatment of bladder cancer in China – Analyses of Chinese Bladder Cancer Consortium Database

28. WITHDRAWN: Prostate cancer in Asia: A collaborative report

29. Prostate cancer in Asia: A collaborative report

Catalog

Books, media, physical & digital resources